http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104352520-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26 |
| filingDate | 2014-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104352520-B |
| titleOfInvention | Calf spleen extract and the purposes in the treatment of primary immune thrombocytopenia |
| abstract | The present invention provides a kind of purposes of calf spleen extract in the treatment of primary immune thrombocytopenia.The preparation process of the calf spleen extract is to include the preparation of homogenate, freeze thawing, combination enzyme synergistic effect, pH adjust and membrane filtration and be sterile filtered and it is filling.Extraction rate of polypeptide and ribose greatly increases in the school ox spleen extract and glycopeptide ratio is fixed between 80 87.Calf spleen extract can treat the activity of ITP by CD4 in platelet count and each immune organ + CD25 + T ratios are verified that the results show present invention can significantly improve 50% that platelet levels reach former technique, and improve hematopoiesis function, have no toxic side effect. |
| priorityDate | 2014-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.